Ginkgolide B suppresses intercellular adhesion molecule-1 expression via blocking nuclear factor-κB activation in human vascular endothelial cells stimulated by oxidized low-density lipoprotein

Journal of Pharmacological Sciences

Volumn 110, Issue 3, 2009, Pages 362-369

  Li, Rui ^a,b   Chen, Beidong ^a   Wu, Wei ^a   Bao, Li ^a   Li, Jian ^a   Qi, Ruomei ^a  

^a BEIJING HOSPITAL   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Endothelial cell; Ginkgolide B; Intercellular adhesion molecule 1 (ICAM 1); Nuclear factor B (NF B); Oxidized low density lipoprotein (LDL)

Indexed keywords

GINKGOLIDE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL NUCLEUS; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM; VASCULITIS;

EID: 67749139804     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08275FP     Document Type: Article

References (38)

1. Pincemail J, Dupuis M, Nasr C, Hans P, Haag-Berrurier M, Anton R, et al. Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia. 1989;45:708-712. (Pubitemid 19198311)
2. Marcocci L, Packer L, Droy-Lifaix MT, Sekaki A, Gardès-Albert M. Antioxidant action of Ginkgo biloba extract EGb 761. Method Enzymol. 1994;234:462-475. (Pubitemid 24330318)
3. Vogensen SB, StrØmgaard K, Shindou H, Jaracz S, Suehiro M, Ishii S, et al. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists. J Med Chem. 2003;46:601-608. (Pubitemid 36182761)
4. Li S, Meng Q, Zhang L. Experimental therapy of a plateletactivating factor antagonist (ginkgolide B) on photochemically induced thrombotic cerebral ischemia in tree shrews. Clin Exp Pharmacol Physiol. 1999;26:824-825. (Pubitemid 29477002)
5. Nishida S, Satoh H. Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta. Life Sci. 2003;72:2659-2667. (Pubitemid 36369704)
6. Lamant V, Mauco G, Braquet P, Chap H, Douste H, Douste-Blazy L. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol. 1987;36:2749-2752.
7. Braquet P. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane Leukot Res. 1986;16:179-198.
8. Rodríguez M, Ringstad L, Schäfer P, Just S, Hofer HW, Malmsten M, et al. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients. Atherosclerosis. 2007;192:438-444. (Pubitemid 46726344)
9. Vellas B, Andrieu S, Ousset PJ, Ouzid M, Mathiex-Fortunet H, GuidAge Study Group. The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint. Neurology. 2006;67:S6-S11.
10. Gohil K, Packer L. Bioflavonoid-rich botanical extracts show antioxidant and gene regulatory activity. Ann N Y Acad Sci. 2002;957:70-77. (Pubitemid 34721654)
11. Tsimikas S. Oxidized low-density lipoprotein is biomarkers in atherosclerosis. Curr Atheroscler Rep. 2006;8:55-61. (Pubitemid 43675755)
12. Ross R. The pathgenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
13. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966. (Pubitemid 27373946)
14. de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappa B signaling in atherogenesis. Arteroscler Thromb Vasc Biol. 2005;25:904-914. (Pubitemid 40627833)
15. Burleigh ME, Babaev VR, Yancey PG, Major AS, McCaleb JL, Oates JA, et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. J Mol Cell Cardiol. 2005;39:443-452.
16. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000;191:189-194. (Pubitemid 30043660)
17. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998;2:275-281. (Pubitemid 128373654)
18. Weil R, Whiteside ST, Israel A. Control of NF-kappa B activity by the I kappa B beta inhibitor. Immunobiology. 1997;198:14-23. (Pubitemid 28021378)
19. Zhao JJ, Qi RM, Li R, Wu W, Gao X, Bao L, et al. Protective effects of aspirin against oxidized LDL-induced inflammatory protein expression in human endothelial cells. J Cardiovasc Pharmacol. 2008;51:32-37.
20. Sakurai K, Sawamura T. Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationships with oxidative stress. J Pharmacol Sci. 2003;91:182-186. (Pubitemid 36575574)
21. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDLmediated upregulation of monocyte chemattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000;101:2889-2895. (Pubitemid 30415877)
22. Yang CM, Chiu CT, Wang CC, Chien CS, Hsiao LD, Lin CC, et al. Activation of mitogen-activated protein kinase by oxidized low-density lipoprotein in canine culatured vascular smooth muscle cells. Cell Signal. 2000;20:135-143.
23. Marathe GK, Davies SS, Hrarison KA, Silva AR, Murphy RC, Castro-Faria-Neto H, et al. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Bio Chem. 1999; 274:28395-28404. (Pubitemid 129504708)
24. Chintala M, Shimizu K, Ogawa M, Yamaguchi H, Doi M, Jensen P. Basic and translational research on proteinaseactivated receptors: antagonism of the proteinase-activated receptor 1 for thrombin, a novel approach to antiplatelet therapy for atherothrombotic disease. J Pharmacol Sci. 2008;108:433-438.
25. Kevil CG, Patel RP, Bullard DC. Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells. Am J Physiol Cell Physiol. 2001;281:C1442-C1447. (Pubitemid 33121667)
26. Esteban V, Ruperez M, Sánchez-López E, Rodríguez- Vita J, Lorenzo O, Demaegdt H, et al. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells. Circ Res. 2005;96:965-973. (Pubitemid 40712796)
27. Murase T, Kume N, Hase T, Shibuya Y, Nishizawa Y, Tokimitsu I, et al. Gallates inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19:1412-1420. (Pubitemid 29263010)
28. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Saito T, et al. C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells. Atherosclerosis. 2006;185:39-46. (Pubitemid 43117549)
29. Schreck R, Meier B, Männel DN, Dröge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 1992;175:1181-1194.
30. Liu SF, Ye X, Malik AB. Inhibition of NF-kappaB activation by pyrrolidine dithacarbamate prevent. In vivo expression of proinflammatorry genes. Circulation. 1999;100:1330-1337.
31. Cuzzocrea S, Chatterjee PK, Mazzon F, Dugo L, Serrain I, Britti D, et al. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol. 2002;135: 496-510. (Pubitemid 34151183)
32. Chen XP, Xun KL, Wu Q, Zhang TT, Shi JS, Du GH. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vascul Pharmacol. 2007;47:1-9. (Pubitemid 46830770)
33. 2+ currents via lysophosphatidylcholine- induced mitochondrial reactive oxygen species (ROS) production. Cardiovasc Res. 2006;69:855-864.
34. Zmijewski JW, Landar A, Watanabe N, Dickinson DA, Noguchi N, Darley-Usmar VM. Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. Biochem Soc Trans. 2005;33:1385-1389. (Pubitemid 41779694)
35. Hsieh CC, Yen MH, Yen CH, Lau YT. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc Res. 2001;49:135-145.
36. Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol. 2005;25:1332-1340.
37. Liu H, Colavitti R, Rovira II, Finke T. Redox-dependent transcriptional regulation. Circ Res. 2005;97:967-974.
38. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005;25:29-38.